Authors: Maliepaard, M van Gastelen, MA Tohgo, A Hausheer, FH van Waardenburg, RCAM de Jong, LA Pluim, D Beijnen, JH Schellens, JHM

Citation: M. Maliepaard et al., Circumvention of breast cancer resistance protein (BCRP)-mediated resistance to camptothecins in vitro using non-substrate drugs or the BCRP inhibitor GF120918, CLIN CANC R, 7(4), 2001, pp. 935-941

Authors: Chaudhuri, AR Seetharamalu, P Schwarz, PM Hausheer, FH Luduena, RF

Citation: Ar. Chaudhuri et al., The interaction of the B-ring of colchicine with alpha-tubulin: A novel footprinting approach, J MOL BIOL, 303(5), 2000, pp. 679-692

Authors: Van Hattum, AH Pinedo, HM Schluper, HMM Hausheer, FH Boven, E

Citation: Ah. Van Hattum et al., New highly lipophilic camptothecin BNP1350 is an effective drug in experimental human cancer, INT J CANC, 88(2), 2000, pp. 260-266

Authors: Matsui, SI Endo, W Wrzosek, C Haridas, K Seetharamulu, P Hausheer, FH Rustum, YM

Citation: Si. Matsui et al., Characterisation of a synergistic interaction between a thymidylate synthase inhibitor, ZD1694, and a novel lipophilic topoisomerase I inhibitor karenitecin, BNP1100: Mechanisms and clinical implications, EUR J CANC, 35(6), 1999, pp. 984-993

Authors: Pavankumar, PNV Seetharamulu, P Yao, S Saxe, JD Reddy, DG Hausheer, FH

Citation: Pnv. Pavankumar et al., Comprehensive ab initio quantum mechanical and molecular orbital (MO) analysis of cisplatin: Structure, bonding, charge density, and vibrational frequencies, J COMPUT CH, 20(3), 1999, pp. 365-382